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Sequencing by ligationcing technologies, from Illumina/Solexa, ABI/SOLiD, 454/Roche, and Helicos, has
provided unprecedented opportunities for high-throughput functional genomic research. To date, these
technologies have been applied in a variety of contexts, including whole-genome sequencing, targeted
resequencing, discovery of transcription factor binding sites, and noncoding RNA expression proﬁling. This
review discusses applications of next-generation sequencing technologies in functional genomics research
and highlights the transforming potential these technologies offer.
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256 O. Morozova, M.A. Marra / Genomics 92 (2008) 255–264Since ﬁrst introduced to the market in 2005, next-generation
sequencing technologies have had a tremendous impact on genomic
research. The next-generation technologies have been used for
standard sequencing applications, such as genome sequencing and
resequencing, and for novel applications previously unexplored by
Sanger sequencing. In this review we ﬁrst describe the three
commercially available next-generation sequencing technologies in
comparison to a state-of-the-art Sanger sequencer, and follow this
with a discussion of the novel kind of data produced by next-
generation sequencers and the issues associated with it. We then turn
our attention to the application of next-generation sequencing
technologies to functional genomics research, particularly focusing
on transcriptomics and epigenomics. We end with a discussion of
future prospects that next-generation technologies hold for functional
genomics research. This review does not address genome sequencing
and resequencing applications of next-generation sequencers [1] or
the huge impact these technologies have had in metagenomics
(reviewed in [2]).
Advances in DNA sequencing technologies
The landmark publications of the late 1970 s by Sanger's and
Gilbert's groups [3,4] and notably the development of the chain
termination method by Sanger and colleagues [5] established the
groundwork for decades of sequence-driven research that followed.
The chain-termination method published in 1977 [5], also commonly
referred to as Sanger or dideoxy sequencing, has remained the most
commonly used DNA sequencing technique to date and was used to
complete human genome sequencing initiatives led by the Interna-
tional Human Genome Sequencing Consortium and Celera Genomics
[6–8]. Very recently, the Sanger method has been partially supplanted
by several “next-generation” sequencing technologies that offer
dramatic increases in cost-effective sequence throughput, albeit at
the expense of read lengths. The next-generation technologies
commercially available today include the 454 GS20 pyrosequencing-
based instrument (Roche Applied Science), the Solexa 1G analyzer
(Illumina, Inc.), the SOLiD instrument from Applied Biosystems, and
the Heliscope from Helicos, Inc. As of this writing, information on the
performance of the Heliscope in functional genomics applications is
lacking, and so we have restricted our comments to the 454, SOLiD,
and 1G sequencing platforms. These new technologies as well as the
current state-of the-art Sanger sequencing platform are summarized
in Table 1 and discussed in some detail below. For a review of the
history of DNA sequencing the reader is referred to [9]; for a more
comprehensive review of emerging sequencing technologies see [10].Table 1
Advances in DNA sequencing technologies
Technology Approach Read length Bp per run Company name and
Web site
Automated
Sanger
sequencer
ABI3730xl
Synthesis in the
presence of dye
terminators
Up to 900 bp 96 kb Applied Biosystems
www.
appliedbyosystems.
com
454/Roche
FLX system
Pyrosequencing on
solid support
200–300 bp 80–120 Mb Roche Applied
Science www.roche-
applied-science.com
Illumina/
Solexa
Sequencing by
synthesis with
reversible
terminators
30–40 bp 1 Gb Illumina, Inc. http://
www.illumina.com/
ABI/SOLiD Massively parallel
sequencing by
ligation
35 bp 1–3 Gb Applied Biosystems
www.
appliedbyosystems.
comSanger sequencing
Since its initial report in 1977, the Sanger sequencing method has
remained conceptually unchanged. The method is based on the DNA
polymerase-dependent synthesis of a complementary DNA strand in
the presence of natural 2′-deoxynucleotides (dNTPs) and 2′,3′-
dideoxynucleotides (ddNTPs) that serve as nonreversible synthesis
terminators [5]. The DNA synthesis reaction is randomly terminated
whenever a ddNTP is added to the growing oligonucleotide chain,
resulting in truncated products of varying lengths with an appropriate
ddNTP at their 3′ terminus. The products are separated by size using
polyacrylamide gel electrophoresis and the terminal ddNTPs are used
to reveal the DNA sequence of the template strand.
Originally, four different reactions were required per template,
each reaction containing a different ddNTP terminator, ddATP, ddCTP,
ddTTP, or ddGTP. However, advances in ﬂuorescence detection have
allowed for combining the four terminators into one reaction by
having them labeled with ﬂuorescent dyes of different colors [11,12].
Subsequent advances have replaced the original slab gel electrophor-
esis with capillary gel electrophoresis, thereby enabling much higher
electric ﬁelds to be applied to the separation matrix. One effect of this
advance was to enhance the rate at which fragments could be
separated [13]. The overall throughput of capillary electrophoresis was
further increased by the advent of capillary arrays whereby many
samples could be analyzed in parallel [14]. In addition, breakthroughs
in polymer biochemistry, including the development of linear
polyacrylamide [15] and polydimethylacrylamide [16] have allowed
the reuse of capillaries in multiple electrophoretic runs, thus further
increasing sequencing efﬁciency. For further reading on improve-
ments in Sanger sequencing research the reader is referred to [10] and
[17].
These and many other advances in sequencing technology
contributed to the relatively low error rate, long read length, and
robust characteristics of modern Sanger sequencers. For instance, a
commonly used automated high-throughput Sanger sequencing
instrument from Applied Biosystems, the ABI 3730xl, has a 96-
capillary array format and is capable of producing 900 or more PHRED
20 [18] bp per read for a total of up to 96 kb for a 3-h run (Table 1).
However, despite the many advances in chemistries and the robust
performance of instruments like the 3730xl, the application of
relatively expensive Sanger sequencing to large sequencing projects
has remained beyond the means of the typical grant-funded
investigator. This is a limitation that has been apparently successfully
addressed, to varying degrees, by all of the latest technology offerings.
454 sequencing technology: pyrosequencing in high-density
picoliter reactors
An inherent limitation of Sanger sequencing is the requirement of
in vivo ampliﬁcation of DNA fragments that are to be sequenced,
which is usually achieved by cloning into bacterial hosts. The cloning
step is prone to host-related biases, is lengthy, and is quite labor
intensive [2]. The 454 technology [19], the ﬁrst next-generation
sequencing technology released to the market, circumvents the
cloning requirement by taking advantage of a highly efﬁcient in
vitro DNA ampliﬁcation method known as emulsion PCR [20]. In
emulsion PCR, individual DNA fragment-carrying streptavidin beads,
obtained through shearing the DNA and attaching the fragments to
the beads using adapters, are captured into separate emulsion
droplets. The droplets act as individual ampliﬁcation reactors,
producing ∼107 clonal copies of a unique DNA template per bead
[19]. Each template-containing bead is subsequently transferred into a
well of a picotiter plate and the clonally related templates are analyzed
using a pyrosequencing reaction. The use of the picotiter plate allows
hundreds of thousands of pyrosequencing reactions to be carried out
in parallel, massively increasing the sequencing throughput [19]. The
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nique that measures the release of inorganic pyrophosphate (PPi) by
chemiluminescence. The template DNA is immobilized, and solutions
of dNTPs are added one at a time; the release of PPi, whenever the
complementary nucleotide is incorporated, is detectable by light
produced by a chemiluminescent enzyme present in the reaction mix.
The sequence of DNA template is determined from a “pyrogram,”
which corresponds to the order of correct nucleotides that had been
incorporated. Since chemiluminescent signal intensity is proportional
to the amount of pyrophosphate released and hence the number of
bases incorporated, the pyrosequencing approach is prone to errors
that result from incorrectly estimating the length of homopolymeric
sequence stretches (i.e., indels).
The current state-of-the-art 454 platform marketed by Roche
Applied Science is capable of generating 80–120 Mb of sequence in
200- to 300-bp reads in a 4-h run. The 454 technology has been the
most widely published next-generation technology, having so far been
featured in more than 100 research publications (Roche Applied
Sciences).
Illumina: sequencing by synthesis of single-molecule arrays with
reversible terminators
The Illumina/Solexa approach [23–25] achieves cloning-free DNA
ampliﬁcation by attaching single-stranded DNA fragments to a solid
surface known as a single-molecule array, or ﬂow cell, and conducting
solid-phase bridge ampliﬁcation of single-molecule DNA templates
(Illumina, Inc.). In this process, one end of single DNA molecule is
attached to a solid surface using an adapter; the molecules subse-
quently bend over and hybridize to complementary adapters (creating
the “bridge”), thereby forming the template for the synthesis of their
complementary strands. After the ampliﬁcation step, a ﬂow cell with
more than 40 million clusters is produced, wherein each cluster is
composed of approximately 1000 clonal copies of a single template
molecule. The templates are sequenced in a massively parallel fashion
using a DNA sequencing-by-synthesis approach that employs rever-
sible terminators with removable ﬂuorescent moieties and special
DNA polymerases that can incorporate these terminators into growing
oligonucleotide chains. The terminators are labeled with ﬂuors of four
different colors to distinguish among the different bases at the given
sequence position and the template sequence of each cluster is
deduced by reading off the color at each successive nucleotide
addition step. Although the Illumina approach is more effective at
sequencing homopolymeric stretches than pyrosequencing, it pro-
duces shorter sequence reads [25] and hence cannot resolve short
sequence repeats. In addition, due to the use of modiﬁed DNA
polymerases and reversible terminators, substitution errors have been
noted in Illumina sequencing data [9]. Typically, the 1G genome
analyzer from Illumina, Inc., is capable of generating 35-bp reads and
producing at least 1 Gb of sequence per run in 2–3 days.Fig. 1. Sequence census approach. In the sequence census approach used in next-generation
information. Sequence data are used to reveal sequence polymorphisms in the template, e.g.
abundance of the template, and the particular areas of the template covered by reads reveaABI/SOLiD: massively parallel sequencing by ligation
Massively parallel sequencing by hybridization–ligation, imple-
mented in the supported oligonucleotide ligation and detection
system (SOLiD) from Applied Biosystems, has recently become
available. The ligation chemistry used in SOLiD is based on the polony
sequencing technique that was published in the same year as the 454
method [26]. Construction of sequencing libraries for analysis on the
SOLiD instrument begins with an emulsion PCR single-molecule
ampliﬁcation step similar to that used in the 454 technique. The
ampliﬁcation products are transferred onto a glass surface where
sequencing occurs by sequential rounds of hybridization and ligation
with 16 dinucleotide combinations labeled by four different ﬂuor-
escent dyes (each dye used to label four dinucleotides). Using the four-
dye encoding scheme, each position is effectively probed twice, and
the identity of the nucleotide is determined by analyzing the color that
results from two successive ligation reactions. Signiﬁcantly, the two-
base encoding scheme enables the distinction between a sequencing
error and a sequence polymorphism: an error would be detected in
only one particular ligation reaction, whereas a polymorphism would
be detected in both. The newly released SOLiD instrument is capable
of producing 1–3 Gb of sequence data in 35-bp reads per an 8-day run.
Making use of next-generation sequencer data format: pains and
gains of plentiful short reads
Sequence census applications
The read lengths currently achievable by 454 technology are
approaching 300 bp (Roche Applied Sciences), yet are still shorter than
the 700–900 bp achieved by Sanger sequencing. The Illumina and ABI/
SOLiD instruments generate even shorter ∼35-bp reads. The large
numbers of short reads produced by next-generation sequencers
provide opportunities for the development of new applications that
beneﬁt from the particular data format. For instance, next-generation
technologies have been widely applied in contexts whereby sequen-
cing of only a portion of the molecule is sufﬁcient (referred to as
sequence census applications [27]).
The sequence census approach (Fig. 1) uses short reads (or “tags”)
to assign the site of origin of the read instead of determining the
entire sequence of the original DNA molecule. By mapping the
sequence read to its molecule of origin, the presence of the molecule
is established. Signiﬁcantly, the number of reads that map to a
particular nucleic acid species correlates with the abundance of the
species in the cell [28–30]. The sequence census approach is
conceptually similar to the serial analysis of gene expression
(SAGE) method initially developed with Sanger sequencing [31]. In
SAGE, the abundance of a particular mRNA species is estimated from
the count of sequence fragments (tags) derived from its 3′ end [31].
Since the advent of next-generation sequencers that reduce the costsequencing, short reads are mapped to the template molecule to provide three types of
, a SNP (red and yellow), the abundance of reads is used as a quantitative measure of the
l the internal structure of the template, e.g., the presence of exons and introns.
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such sequence census methods has been expanded to include many
research areas [27]. To date, sequence census methods have been
most commonly used for the analysis of transcribed portions of the
genome, such as gene expression and noncoding RNA proﬁling [28–
30]. The applications of these methods for studying transcriptomes
are discussed in more detail in the transcriptome section of this
review.
A novel use of the sequence census approach is the identiﬁcation of
protein binding sites on the DNA using chromatin immunoprecipita-
tion followed by next-generation sequencing (ChIP-Seq) [32–37]. This
technique couples the commonly used chromatin immunoprecipita-
tion procedure, inwhich DNA–protein complexes are cross-linked and
precipitated using an antibody [38], to next-generation sequencing of
DNA fragments bound to the precipitated protein [36]. To date, ChIP-
Seq has been applied to the identiﬁcation of transcription factor
binding sites as well as histone modiﬁcations on a genome-wide scale
[32,34,36,37]. The application of this technology for studying
epigenomes is described in detail in the epigenome section of this
review.
Read pairs and read accuracy issues
A limitation of short-read sequence data is the difﬁculty in de
novo sequence assembly. This shortcoming is particularly an issue in
sequencing new genomes and in sequencing highly rearranged
genome segments, such as one might discover in cancer genomes
[39] or in regions of structural variation [40]. Paired-end sequencing
approaches, in which both ends of a fragment of deﬁned size are
sequenced to provide more information about the fragment, have
the potential to improve the utility of short reads for sequencing
rearranged genomic segments and for de novo sequence assembly
[2,41]. Although widely adopted for Sanger sequencing, in which
paired-end reads are obtained by sequencing both ends of a clone
insert, paired-end approaches are currently in their infancy relative
to most next-generation technologies [2]. A few reports of paired-
end approaches for next-generation sequencers included the paired-
end polony sequencing approach, applied to resequence the genome
of an evolved strain of Escherichia coli [26], and the multiplex
sequencing of paired-end ditags (MS-PET) method for 454 sequen-
cing [42]. More recently, a paired-end mapping (PEM) procedure has
been developed for the 454 technology and used to map structural
rearrangements in two previously studied human genomes [43]. The
results of PEM were in concordance with those obtained from
previous investigations, including the HapMap project [43]. Another
paired-end mapping approach involving paired-end ditags has been
described for the detection of gene fusions and transcribed retro-
transposons [44]. At the time of writing, no paired-end studies have
been reported using Illumina or SOLiD technologies, although both
platforms are developing or have implemented paired-end
approaches.
Given the quantity of reads and their short length, read accuracy
becomes critical for mapping the reads to a reference sequence and for
detecting sequence polymorphisms. The base accuracy, and the
PHRED method [18] for evaluating the quality of Sanger-sequenced
bases, is well established. This is currently not the case for the next-
generation technologies ([2], but see [45]). To compensate for the
uncertainty related to sequence quality and base accuracy, a general
reliance on redundancy of sequence coverage is commonly invoked in
next-generation sequencing. Multiple overlapping reads are thus used
to conﬁrm the accuracy of the base calls in applications in which
accuracy is paramount, such as in the reliable detection of mutations
or sequence polymorphisms [46]. Increasing the accuracy of indivi-
dual base calls will ultimately lead to reductions in the high levels of
redundancy currently invoked for conﬁdent base assignment and thus
will presumably decrease sequencing costs.Transcriptome sequencing by next-generation technologies
The sequencing of cDNA rather than genomic DNA focuses analysis
on the transcribed portion of the genome. This focus reduces the size
of the sequencing target space, which can be viewed as desirable given
the fact that, even with next-generation sequencers, sequencing an
entire vertebrate genome is still an expensive undertaking. Tran-
scriptome sequencing has been used for applications ranging from
gene expression proﬁling, genome annotation, and rearrangement
detection to noncoding RNA discovery and quantiﬁcation. A unique
feature of high-throughput transcriptome sequencing studies is the
versatility of the data, which can simultaneously be analyzed to
provide insight into the level of gene expression, the structure of
genomic loci, and sequence variation present at loci (e.g., SNPs). To
date, the 454 technology has dominated next-generation applications
in transcriptomics; but at least one recent paper describes the use of
the Illumina sequencer for proﬁling microRNAs [30].
Gene expression proﬁling using novel and revisited sequence
census methods
The identiﬁcation and quantiﬁcation of mRNA species under
different conditions or in different cell types have long been of
interest to biologists. Two conceptually different approaches to high-
throughput gene expression proﬁling have emerged in the past
decade to allow the simultaneous interrogation of gene expression
levels on a genome-wide scale [47]. One group of methods is based on
microarrays, in which cDNA is hybridized to an array of complemen-
tary oligonucleotide probes corresponding to genes of interest, and
the abundance of a particular mRNA species is estimated from its
hybridization intensity to the relevant probe [48]. A variety of
microarray-based platforms and techniques have been developed in
recent years; see for review [49].
A conceptually different group of methods uses sequencing of
cDNA fragments followed by counting the number of times a
particular fragment has been observed. This group of methods
includes the well-known SAGE method [31] and the more recent
massively parallel signature sequencing (MPSS) [50]. In SAGE,
restriction enzymes are used to obtain short sequence fragments
(tags) of 14–17 bp, usually derived from the 3′ end of an mRNA; the
tags are concatenated and sequenced to determine the expression
proﬁles of their corresponding mRNAs [31]. The MPSS method also
generates small fragment signatures of each mRNA species; however,
it uses a different protocol that does not involve propagation in
bacteria and a different non-gel-based sequencing method [50]. SAGE
and MPSS are often termed “clone-and-count” techniques as they
provide a digital overview of gene expression proﬁles in a cell [47].
Advantages of such digital readouts include statistical robustness and
less stringent standardization and replication requirements than
those used for microarrays [50,51]. Some disadvantages that have
hindered the use of SAGE andMPSS up until recently included the cost
of sequencing and the biases introduced by the necessary cloning step.
Furthermore, the MPSS technology has been restricted to only a few
specialized laboratories [52].
Despite its excellent performance at detecting highly abundant
transcripts, SAGE as commonly employed (i.e., sequencing to depths of
30,000–200,000 tags) involves relatively limited sequencing that does
not robustly detect rare mRNAs [53]. This is due to the costs incurred
with extensive Sanger sequencing of SAGE libraries. Because of these
costs, no conventionally sequenced SAGE library exhibits saturating
tag number kinetics that would suggest complete representation of
the cellular transcriptome [53]. In contrast, next-generation technol-
ogies offer substantial cost-effective increases in sequencing through-
put, such that millions of sequences can be obtained for a few
thousands of dollars or less. In addition, the short read lengths are
compatible with the short tags generated using SAGE-like library
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described an extension of the SAGE method based on the LongSAGE
protocol [54], for generation of longer tags of 17 bp versus 14 bp in the
original SAGE, and the 454 sequencing technology. The next-
generation sequencing-based SAGE method, termed DeepSAGE,
greatly simpliﬁes the sample preparation procedure by removing
the cloning step and replacing it with emulsion PCR-based ampliﬁca-
tion; the sequencing is conducted by the 454 protocol that allows
multiple samples to be sequenced in a single run at a high depth [52].
In particular, the authors estimate that a typical DeepSAGE experi-
ment would generate 300,000 tags with less effort than a typical
LongSAGE experiment generating 50,000 tags [52]. Nielsen et al. [52]
applied the DeepSAGE protocol to the analysis of the transcriptome of
the potato and showed that it was efﬁcient at detecting rare
transcripts (gauged by examining the expression of potato transcrip-
tion factors) and due to the much increased depth provides more
robust expression level estimates than LongSAGE [52].
A novel sequence census technique for surveying mRNA levels
using 5′-end sequence fragments has been developed and termed
rapid analysis of 5′ transcript ends (5′-RATE) [55]. The technique
involves three steps, 5′ oligocapping of mRNA; ditag formation using
RL-SAGE [56], a modiﬁcation of the LongSAGE protocol; and 454
sequencing of tags. The technique was applied to the analysis of maize
transcripts andwas shown to provide an effectivemeans for surveying
the transcriptome. Some key features of 5′-RATE are the tag length
(∼80 bp), which is longer than that of LongSAGE and MPSS, and the
ability to generate tags from the 5′ end, facilitating the identiﬁcation
of transcription start sites. In addition, similar to DeepSAGE, 5′-RATE is
a relatively simple, fast, and productive procedure that does not
involve cloning.
Other sequencing-based methods such as full-length cDNA
sequencing [57] and the generation of expressed sequence tags
(ESTs), which are single sequencing reads derived from one end of a
cDNA clone [58,59], have been used to characterize cellular mRNA
proﬁles. However, primarily due to the cost of sequencing, these
methods had been even less effective than SAGE at providing a
quantitative and comprehensive representation of cellular transcripts
or transcript variability [60]. With the development of next-
generation sequencing technologies, EST sequencing has gained
potential as one of the sequence census methods for studying mRNA
proﬁles on a genome-wide scale. A number of studies have been
successful at constructing EST libraries using the 454 technology; so far
EST libraries have been constructed from plants, including the mustard
weed Arabidopsis thaliana [61,62], the model legume Medicago
truncatula [63], and maize, Zea mays [64], as well as the insects Dro-
sophila melanogaster [28] and wasp, Polistes metricus [65]. A study
conducted at our Genome Centre used 454 sequencing to generate ESTs
from a human prostate cancer cell line, LNCaP [29]. The 454 technology
is well suited to EST sequencing, as it is currently capable of generating
∼400,000 reads per run [29,63] and provides an unbiased representa-
tion of all regions of a transcript independent of length or expression
level [61]. Importantly, a single 454 run has been shown to provide a
representative view of the mRNA population in the cell [61,63]. Further,
unlike the shorter reads generated using the Illumina or SOLiD
sequencers, the length of the 454 reads allows for interpretation of
sequences generated from species lacking a genome sequence or
extensive transcriptome sequences for comparison (e.g., [66]).
Another novel sequence census approach based on the 454
technology focuses on sequencing unique fragments found at 3′
untranslated regions (3′-UTRs) of genes [67]. This approach is
particularly useful for distinguishing closely related transcripts, such
as those resulting from paralogs, and for studying allele-speciﬁc
expression [67]. In addition, Eveland et al. [67] estimated that 3′-UTR
sequencing is superior to EST sequencing at identifying individual
transcripts owing to the decreased sequencing redundancy achieved
by restricting reads to the 3′-UTR regions of genes [67]. In particular,the authors identiﬁed 47,299 distinct mRNAs compared to 17,500
identiﬁed by a similar EST study in A. thaliana [61]. Signiﬁcantly, the
method does not rely on a complete genome sequence and has been
shown to be successful at surveying transcription in Z. mays, whose
genome is currently being sequenced (Maize Genome Sequencing
Consortium).
Small noncoding RNA proﬁling and the discovery of novel small
RNA genes
A related application of next-generation sequencing technologies
to the analysis of transcriptomes is small noncoding (ncRNA)
discovery and proﬁling. ncRNAs are RNA molecules that are not
translated into a protein product. This class of RNAs includes transfer
RNA (tRNA), ribosomal RNA (rRNA), small nuclear and small nucleolar
RNA, and microRNA and small interfering RNA (miRNA and siRNA).
Recent research has implicated microRNAs, approximately 21-
nucleotide-long RNA molecules, as crucial posttranscriptional reg-
ulators of gene expression in both animals and plants [68]. A related
class of noncoding RNAs, siRNAs, 21–24 nt in length, is the
predominant class of small RNA molecules in plants [69]. Deﬁnite
evidence for the presence of endogenous siRNAs in animals is lacking
[70]. While miRNAs and siRNAs are similar in size and are both
involved in posttranscriptional regulation of gene expression, their
biogenesis and exact functions are different [71].
MicroRNAs were ﬁrst identiﬁed in Caenorhabditis elegans [72] and
since then have emerged as crucial regulators of gene expression in
many organisms, including humans [73]. Historically, novel miRNAs
have been identiﬁed by cloning and sequencing of individual miRNAs,
which involved separating them on gels and successively ligating
adapters at the 5′-end monophosphate and 3′ hydroxyl groups
[70,73]. However, using this approach it was difﬁcult to distinguish
miRNAs fromdegradation products of other ncRNAs in the cell, such as
rRNA or tRNA [70]. More recently, microarray-based approaches have
been developed for high-throughput miRNA proﬁling; however, these
approaches are not suitable for the detection of novel miRNAs [70].
High-throughput sequencing of small RNAs provides great poten-
tial for the identiﬁcation of novel small RNAs as well as proﬁling of
known and novel small RNA genes. The MPSS technology has been
applied to the sequencing of size-fractionated small RNAs from A.
thaliana [69]. This approach involved the generation of 17-nt
fragments corresponding to parts of mature small RNA molecules
and using bioinformatic analysis to identify the corresponding small
RNA genes in the genome [69]. Several disadvantages of this approach
are the high complexity and cost of the MPSS technology, which
involves a cloning step, and the short read lengths corresponding to
only a portion of small RNA molecules [70].
Next-generation sequencing technologies do not involve cloning
and produce read lengths compatible with the length of mature
miRNAs and siRNAs. This provides several important advantages
for ncRNA sequencing studies over MPSS; the advantages include the
decreased procedural complexity and cost and the dramatically
increased throughput and depth of coverage. Small RNA proﬁling
studies with next-generation sequencing technologies currently
include gel-based separation of small RNAs and construction of
cDNA libraries followed by sequencing on a next-generation
platform.
To date, small RNA proﬁling studies involving the 454 technology
have been reported. These include studies in the moss Physcomitrella
patens [74]; A. thaliana [74–80]; wheat, Triticum aestivum [81]; the
basal eudicot species Eschscholzia californica [82]; the lycopod Selagi-
nella moellendorfﬁi [74]; the unicellular alga Chlamydomonas rein-
hardtii [83]; Marek disease virus [84]; and primates [85]. Importantly,
small RNA sequencing studies with the 454 technology contributed to
the discovery of a novel class of small RNAs, termed Piwi-interacting
RNAs, that are expressed in mammalian testes and are presumably
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[86–88].
The Illumina and SOLiD platforms allow for the generation of
several millions of short 35-nt reads in comparison to up to 500,000
reads generated by the 454 technology [74], potentially providing
even deeper coverage of small RNAs than the 454 platform. Our
laboratory has recently used the Illumina technology to sequence
small RNA libraries from human embryonic stem cells before and
after their differentiation into embryonic bodies [30]. This study
generated more than 6 million short sequence reads from each
library and identiﬁed 334 known and 104 novel miRNA genes in one
of the most comprehensive miRNA proﬁling exercises to date [30].
High-throughput sequencing-based approaches to small ncRNA
proﬁling, hugely enabled by next-generation technologies, provide
several advantages over microarray methods, including the ability to
discover novel miRNAs and the potential to detect variations in the
mature miRNA length and miRNA editing [30]. We envision that such
approaches will gain even more popularity in the near future as the
Illumina and SOLiD platforms are exploited in more laboratories.
Protein coding gene annotation using transcriptome sequence data
Despite the explosion of genome sequence data from multiple
species fueled by advances in sequencing technologies, genome
annotation for most multicellular eukaryotic species is still at its
rudimentary stages. In particular, recent annotation efforts have
focused on the discovery of novel noncoding RNA genes and
regulatory elements that determine temporal or spatial gene expres-
sion; however, the annotation of protein-coding genes involving the
elucidation of their correct exon–intron structures largely has lagged
behind [89].
The current gold standard for protein-coding gene annotation is
EST or full-length cDNA sequencing followed by alignment to a
reference genome assembly [89]. The cDNA sequences can be aligned
either to the locus fromwhich they had been derived (cis-alignments)
or to a homologous locus from the source genome or the genome of a
related organism (trans-alignments). It has been estimated that most
EST sequencing projects fail to cover 20–40% of transcripts, which
usually include rare or very long transcripts as well as transcripts with
highly speciﬁc expression patterns [89]. Another challenge of EST-
driven gene annotation is alternative splicing and the complex
structure of many loci from multicellular eukaryotes, resulting in a
substantial number of incomplete annotations. Next-generation
sequencing technologies have the potential for providing much
deeper coverage of EST libraries; however, the short reads may be
problematic when annotating alternative splice variants and the
complete accurate structures of protein coding loci [89].
A recent study used laser capture microdissection [90] to isolate
transcripts from the shoot apical meristem of Z. mays followed by
cDNA library construction and 454 sequencing of ESTs [91]. The study
used a cis-alignment method to annotate more than 25,000 genomic
sequences from maize and detect transcription from 400 orphan
genes, most of which had not been detected using other approaches
[91]. Another study used the 454 technology to generate 391,157 EST
reads from the brain transcriptome of the wasp P. metricus; the reads
were then trans-aligned to the genome sequence and EST resources
from the honeybee, Apis mellifera, to annotate P. metricus transcripts
[65]. Interestingly, the study found wasp EST matches to 39% of the
honeybee mRNAs and observed a strong correlation between the
expression levels of the corresponding transcripts from the two
species. Signiﬁcantly, many gene expression proﬁling studies that use
high-throughput sequencing can also provide annotation information,
such as the presence of novel genes, exons, or splice events. For
instance, our own study involving the generation of ESTs from the
prostate cancer cell line LNCaP characterized 25 novel splicing events
[29]. Another example is the 5′-RATE method [55] described above,which is particularly useful for providing annotation information
about transcriptional start sites and other molecular events involving
the 5′ end of transcripts. In addition, 454 transcriptome sequencing
data can be useful for identifying SNPs in coding regions [92].
However, as mentioned earlier, error rates associated with next-
generation sequencers require a relatively high fold coverage to call a
sequence polymorphism reliably, particularly in a heterozygous
sample [46].
The much deeper sequencing capacity of next-generation sequen-
cing comes at the cost of shorter reads, which create additional
challenges for gene annotation (e.g., difﬁculties in resolving splice
isoforms). Paired-end sequencing approaches, such as the newly
developed 454 sequencing-based MS-PET strategy, may facilitate
annotation studies by providingmate pair information from large DNA
fragments [42].
Detection of aberrant transcription events
Genome rearrangements resulting in aberrant transcriptional
events are hallmarks of human cancers [93]. Techniques for detecting
such genome rearrangements include cytogenetic and PCR methods
as well as high-throughput array-based approaches, most notably
array comparative genomic hybridization and sequencing-based
techniques. Sequencing methods for genome rearrangement detec-
tion offer several advantages over array methods, such as the ability to
detect multiple types of rearrangements, including previously
unknown ones; the detection of absolute rather than relative changes
in sequence copy numbers; and the potential for single-nucleotide
resolution [39]. Large-scale transcriptome sequencing studies provide
a novel means for detecting genome rearrangements in the tran-
scribed portion of the genome. However, due to the short-read-length
issue, single-end transcriptome sequencing studies using next-
generation technologies, including the discussed EST studies, would
be of limited use for identifying rearrangements [44].
An elegant gene identiﬁcation signature analysis using paired-end
ditag transcriptome sequencing methodology has been developed for
the detection of gene fusions and other aberrant transcripts in cancers
[44]. The approach involves generation of 18-nt-long tags from both
ends of a transcript, which are then concatenated and sequenced by
the 454 technology. This strategy is particularly useful for detecting
fusion events in cancers, as well as actively transcribed pseudogenes
that are readily distinguishable from their source genomic loci [44].
Related technologies involving other next-generation sequencing
platforms are currently being developed by several laboratories.
Applications of next-generation sequencing for the analysis of
epigenetic modiﬁcations of histones and DNA
Epigenetics is the study of heritable gene regulation that does not
involve the DNA sequence. The two major types of epigenetic
modiﬁcations regulating gene expression are DNA methylation by
covalent modiﬁcation of cytosine-5′ and posttranslational modiﬁca-
tions of histone tails [94]. Regulatory RNAs provide another means of
epigenetic regulation of gene expression; however, the focus of this
section is on applications of next-generation sequencing to the
analysis of covalent modiﬁcations of DNA and chromatin. Recent
research has implicated such epigenetic modiﬁcations of prime
importance in oncogenesis and development, setting the grounds
for the Human Epigenome Project (HEP) initiative, which aims to
catalog DNA methylation patterns on a genome-wide scale [95]. The
next-generation sequencing technologies offer the potential to
accelerate epigenomic research substantially. To date, these technol-
ogies have been applied in several epigenomic areas, including the
characterization of DNA methylation patterns, posttranslational
modiﬁcations of histones, and nucleosome positioning on a gen-
ome-wide scale.
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Cataloging genome-wide DNA methylation patterns, the most
commonly studied epigenetic modiﬁcation, is the primary goal of the
HEP [95]. As part of the project, methylation proﬁles have been
generated for chromosomes 6, 20, and 22 in 12 different tissues using
bisulﬁte DNA sequencing on a Sanger instrument [96]. There are three
main approaches to detecting DNA methylation on a large scale,
including restriction endonuclease digestion coupled to microarray
technology, bisulﬁte sequencing, and immunoprecipitation of 5′-
methylcytosine to separate methylated from unmethylated DNA (for
details see review by Callinan and Feinberg [94]). Bisulﬁte sequencing,
the approach used in the HEP, is based on the chemical property of
bisulﬁte to induce the conversion of cytosine residues to uracils while
leaving 5′-methylcytosines intact. Therefore, sequencing of bisulﬁte-
treated DNA will reveal the positions of methylated cytosines (those
positions that remained cytosines following the treatment). A recent
study by Taylor et al. [97] improved upon the bisulﬁte DNA sequencing
procedure by using the 454 technology to sequence bisulﬁte-treated
PCR amplicons corresponding to gene-related CpG-rich regions. The
method, termed ultradeep bisulﬁte sequencing, was applied to
examine methylation patterns at 25 gene-related CpG-rich regions
in several hematopoietic tumors. The study generated N1600
individual sequences from each amplicon in contrast to the approxi-
mately 20 clones typically generated by conventional bisulﬁte
sequencing, providing a superior robust alternative that does not
involve cloning and allows for the simultaneous analysis of multiple
genes and multiple samples [97]. A similar study using the Illumina
technology has been recently reported [98].
Sequence census applications for mapping histone modiﬁcations and the
locations of DNA-binding proteins
Posttranslational covalent modiﬁcations of histone tails, which
include methylation, acetylation, phosphorylation, and ADP-ribosylation,
are thought to control gene expression by regulating the strength of DNA–
histone interactions determining the accessibility of DNA to transcrip-
tional regulators [99]. Historically, histone modiﬁcations have been
identiﬁed by chromatin immunoprecipitation (ChIP) which, in brief,
involves cross-linking proteins to DNA, followed by immunoprecipitation
of a protein of interestwith a speciﬁc antibody, and characterization of the
bound DNA by hybridization [38] or PCR ampliﬁcation [100]. The
genome-wide development of the ChIP method using microarrays,
known as ChIP–chip, combined the ChIP procedure with hybridization
to a microarray to reveal the genome-wide distribution of the protein of
interest [101].
Sequence census methods have been recently coupled to the basic
ChIP protocol to provide an alternative method for surveying histone
modiﬁcations on a genome-wide scale. Roh et al. [102] used ChIP
followed by a Sanger sequencing-based SAGE procedure (also referred
to as the genome-wide mapping technique) to study the distribution of
acetylated histones H3 and H4 in the yeast genome [102]. Bhinge et al.
[103] replaced Sanger sequencing with the 454 sequencing technology
and termed the method sequence tag analysis of genomic enrichment
(STAGE). STAGE was successfully applied to identifying the genome-wide
binding locations of the STAT1 transcription factor [103]; however, as in
the case of the ChIP–SAGE protocol, it can also be used for the detection of
histone modiﬁcations. Importantly, in these two methods the sequence
reads are derived from the areas of ChIP DNA that are next to a restriction
endonuclease site used in SAGE.
The introduction of next-generation sequencing to the ﬁeld has
brought about the development of a new sequencing-based method,
named ChIP–Seq, for detecting histone modiﬁcations on a genome-
wide scale. In this method, immunoprecipitated DNA is used to
construct sequencing libraries for analysis on a next-generation
sequencer to generate short sequence reads that, in contrast to ChIP–SAGE or STAGE, could be derived from either end of a ChIP DNA
fragment regardless of the presence of a restriction site [35,36]. The
number of reads that map to a particular genomic area can be used to
quantify the strength of binding of the protein of interest in this area
(or the amount of the assayed histone modiﬁcation found at the site).
To date, Illumina technology has been most commonly used for the
ChIP–Seq application. The 25- to 30-bp read length obtained on an
Illumina sequencer sufﬁces to map a typical 150- to 200-bp ChIP DNA
fragment that may be sequenced from both ends. ChIP–Seq has been
applied to the identiﬁcation of histone modiﬁcations on a genome-
wide scale in the human genome [32,37]. In addition, it has been also
used to reveal the genome-wide locations of transcription factor
binding sites of STAT1 and NRSF [34,36].
Of the genome-wide extensions of the ChIP protocol, ChIP–Seq has
the potential for the highest resolution as its resolution depends only
on the size of the input chromatin fragments and the depth of
sequencing. On the other hand, the resolution of ChIP–SAGE (STAGE)
also depends on the distribution of the restriction enzyme sites in the
input ChIP DNA. The resolution of ChIP–chip depends on the resolution
of probes used for the microarray. Both ChIP–SAGE and ChIP–Seq
require less PCR ampliﬁcation than ChIP–chip and, therefore, may
provide improved accuracy for quantifying the binding signal [99].
Applications of next-generation sequencers to the study of DNA
accessibility and chromatin structure
Next-generation sequencing technologies have been applied to
mapping out the positions of nucleosomes and other determinants of
DNA accessibility. Nucleosomes are important factors affecting gene
regulation and are usually associated with decreased accessibility of
DNA to regulatory proteins. Most commonly, nucleosomes are
identiﬁed by preferential cleavage of linker DNA by micrococcal
nuclease (MNase) [99]. The identity of MNase digestion products,
revealed by hybridization or sequencing, marks the locations of
nucleosomes. Two recent studies used MNase digestion followed by
sequencingwith the 454 technology tomap genome-wide locations of
nucleosomes H2A.Z in yeast [104] and nucleosome cores in C. elegans
[105]. Albert et al. [104] used MNase digestion followed by
immunoprecipitation with an anti-H2A.Z antibody to isolate prefer-
entially nucleosomes associated with the particular histone, while
Johnson et al. [105] directly sequenced fragments liberated by
digestion.
ChIP–Seq data from genome-wide histone modiﬁcation proﬁling
experiments can also be used to infer nucleosomal positions on a
genome-wide scale. For instance, Schmid and Bucher [106] used ChIP–
Seq data obtained by Barski et al. [37] to map the positions of two
types of nucleosomes, as well as RNA PolII transcription preinitiation
complexes in human CD4+ T cells. They achieved this by separately
analyzing sequence tags from two DNA strands and assuming that the
tags mapping to the sense and antisense strands deﬁned the 5′ and 3′
boundaries, respectively, of protein–DNA complexes [106]. The results
obtained from this analysis correlated well with similar ﬁndings by
Albert et al. [104], who determined the distribution of H2A.Z
nucleosomes in yeast and found strong phasing of this type of
nucleosome downstream of transcription start sites [104]. The use of
ChIP–Seq data to map the nucleosome positions has three main
limitations. First, only nucleosomes associated with a speciﬁc histone
modiﬁcation can be mapped in this manner; second, nucleosome
positioning is regulated by certain histone modiﬁcations which can,
for instance, mark a given nucleosome for removal [107]; and third,
the method is not quantitative, as the abundance of reads mapping to
a particular region is correlated with the abundance of the histone
modiﬁcation, which is not necessarily correlated with the abundance
of the nucleosome [37].
Other uses of the pyrosequencing technology in epigenomics have
included identifying DNase I-hypersensitive sites to help infer the role
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of the chromosome conformation capture (3C) method to detect
higher order chromosomal structures or physical interactions
between genomic loci in a high-throughput manner [109]. The
original 3C method uses formaldehyde cross-linking followed by
restriction enzyme digestion and intramolecular ligation to detect
physically interacting genomic loci that are presumably important for
regulating gene expression. The abundance of a particular ligation
product (detected by quantitative PCR) is a measure of the frequency
with which the particular loci interact in the nucleus. The sequencing
development of 3C, termed chromosome conformation capture
carbon copy (5C), replaces the quantitative PCR detection by 454
sequencing, enabling the use of the 3C approach on a genome-wide
scale. The 5C approach successfully identiﬁed known and novel
looping interactions involving the β-globin locus [109].
Concluding remarks
Due to their much improved cost effectiveness, compared to
Sanger sequencing, and their many different uses, next-generation
sequencing approaches are poised to emerge as the dominant
genomics technology. Perhaps most signiﬁcantly, these new sequen-
cers have provided genome-scale sequencing capacity to individual
laboratories in addition to larger genome centers. Compared to Sanger
sequencing, advantages of the next-generation technologies men-
tioned thus far, including 454/Roche [19], Illumina/Solexa [24], and
ABI/SOLiD [26], alleviate the need for in vivo cloning by clonal
ampliﬁcation of spatially separated single molecules using either
emulsion PCR (454/Roche and ABI/SOLiD) or bridge ampliﬁcation on
solid surface (Illumina/Solexa). In addition to providing a means for
cloning-free ampliﬁcation, these methods use single-molecule tem-
plates allowing for the detection of heterogeneity in a DNA sample
(e.g., identifying mutations present only in a subpopulation of cells),
which is a signiﬁcant advantage over Sanger sequencing [25,46].
The short read structure of next-generation sequencers provides
potential problems for sequence assembly particularly in areas
associated with sequence repeats. However, it has found broad
applicability in sequence census studies, wherein determining the
sequence of the whole DNA molecule is not essential [27]. The short
read length also necessitates the development of paired-end sequen-
cing approaches for improved mapping efﬁciency [41]. To date, such
approaches have been reported for the 454 technology (e.g., Korbel
et al. [43]) and are being made available for the Illumina and SOLiD
platforms. The accuracy of next-generation sequencers is improving,
but users generally rely on relatively high redundancy of sequence
coverage to determine reliably the sequence of a region, particularly of
that containing a polymorphism [46]. Addressing the accuracy issue
by improving the reaction chemistry has the potential of further de-
creasing the current sequencing cost associated with next-generation
sequencers.
Next-generation sequencing technologies have found broad
applicability in functional genomics research. Their applications in
the ﬁeld have included gene expression proﬁling, genome annotation,
small ncRNA discovery and proﬁling, and detection of aberrant
transcription, which are areas that have been previously dominated
by microarrays. Signiﬁcantly, several studies found that 454 sequen-
cing correlated well with the established gene expression proﬁling
technologies such as microarray results (correlation coefﬁcients of
0.83–0.91) [28] and moderately with SAGE data (correlation coefﬁ-
cients of 0.45) [29]. While the transcriptome sequencing studies
discussed here predominantly used the 454 technology, Illumina and
SOLiD technologies also offer signiﬁcant potential for such applica-
tions. Another major functional genomic application is determining
DNA sequences associated with epigenetic modiﬁcations of histones
and DNA. Next-generation sequencing approaches have been used in
this ﬁeld to proﬁle DNA methylations, posttranslational modiﬁcationsof histones, and nucleosome positions on a genome-wide scale. While
these areas have been previously addressed by Sanger sequencing,
next-generation technologies have improved upon the throughput,
the depth of coverage, and the resolution of Sanger sequencing
studies.
Despite the recent exciting research advances involving next-
generation sequencers, it should be noted that method development
is still in its infancy. Efﬁcient data analysis pipelines are required for
many applications before they become routine, and more studies are
needed to address the robustness of these techniques as well as the
correspondence of results with those obtained by previous methods.
Although next-generation sequencers are already being widely used,
there are other sequencing methods, such as nanopore sequencing
[110], whose scalability is being explored to decrease the sequencing
cost and enhance throughput even further.
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